切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2014, Vol. 03 ›› Issue (02) : 74 -78. doi: 10.3877/cma.j.issn.2095-3232.2014.02.003

所属专题: 文献

临床研究

肝细胞癌破裂亚临床出血患者择期肝切除术后的生存预后分析
孔杰1, 吴力群1,()   
  1. 1. 266003 青岛大学医学院附属医院肝胆外科
  • 收稿日期:2014-01-13 出版日期:2014-04-10
  • 通信作者: 吴力群

Survival and prognostic analysis of ruptured hepatocellular carcinoma patients with subclinical bleeding after elective hepatectomy

Jie Kong1, Liqun Wu1,()   

  1. 1. Department of Hepatobiliary Surgery, the Affiliated Hospital of Medical College, Qingdao University, Qingdao 266003, China
  • Received:2014-01-13 Published:2014-04-10
  • Corresponding author: Liqun Wu
  • About author:
    Corresponding author: Wu Liqun, Email:
引用本文:

孔杰, 吴力群. 肝细胞癌破裂亚临床出血患者择期肝切除术后的生存预后分析[J]. 中华肝脏外科手术学电子杂志, 2014, 03(02): 74-78.

Jie Kong, Liqun Wu. Survival and prognostic analysis of ruptured hepatocellular carcinoma patients with subclinical bleeding after elective hepatectomy[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2014, 03(02): 74-78.

目的

探讨肝细胞癌(肝癌)破裂亚临床出血患者择期肝切除术后的预后。

方法

回顾性分析1997年1月至2010年12月在青岛大学医学院附属医院肝胆外科行择期肝切除术的614例肝癌患者临床资料。所有患者均签署知情同意书,符合医学伦理学规定。根据有否出现肝癌破裂亚临床出血,将患者分为破裂组和非破裂组。其中破裂组30例,男25例,女5例,年龄29~73岁,中位年龄55岁;非破裂组584例,男488例,女96例,年龄14~82岁,中位年龄55岁。所有患者均行肝切除术。观察破裂组与非破裂组患者的临床特征。患者术后均接受随访,观察患者存活情况、死亡原因。根据随访结果绘制Kaplan-Meier生存曲线,比较两组患者的存活情况。分析临床参数与破裂组患者预后的关系。两组临床参数比较采用χ2检验或Fisher确切概率法。组间多因素分析采用Logistic回归分析。生存分析和比较采用Kaplan-Meier法和Log-rank检验,预后危险因素分析采用Cox比例风险回归模型分析。

结果

破裂组中非完全切除、肝切除范围>1段、手术切缘<0.5 cm、术中输血、术中出血量≥1 000 ml、肿瘤直径>5 cm和肿瘤组织学低分化者明显多于非破裂组(χ2=37.609,6.021,6.497,20.982,19.498,22.944,8.222;P<0.05)。进一步Logistic回归分析显示,非完全切除和肿瘤直径>5 cm是肝癌破裂亚临床出血的独立危险因素(OR=3.772,5.045;P<0.05)。随访期间破裂组死亡26例,非破裂组死亡316例。Kaplan-Meier分析显示,破裂组的中位生存期为9个月,非破裂组为56个月;破裂组患者肝切除术后的1、3、5年累积生存率分别为50.0%、22.2%、5.9%,非破裂组为86.0%、62.6%、48.9%,差异有统计学意义(χ2=38.879,P<0.05)。Cox比例风险回归模型分析显示,肿瘤组织学低分化是破裂组患者肝切除术后预后的独立危险因素(RR=3.736,P<0.05)。

结论

非完全切除和肿瘤直径>5 cm是肝癌破裂亚临床出血的独立危险因素。肝癌破裂亚临床出血患者择期肝切除术后预后仍较差,肿瘤组织学低分化是影响其预后的独立危险因素。

Objective

To discuss the prognosis of ruptured hepatocellular carcinoma (HCC) patients with subclinical bleeding after elective hepatectomy.

Methods

Clinical data of 614 patients with HCC who underwent elective hepatectomy in Department of Hepatobiliary Surgery, the Affiliated Hospital of Medical College, Qingdao University from January 1997 to December 2010 were analyzed retrospectively. The informed consents of all patients were obtained and the ethical committee approval was received. According to whether the patients had subclinical bleeding following ruptured HCC or not, they were devided into ruptured group (n=30; 25 males, 5 females; 29 to 73 of age, 55 of median age) and non-ruptured group (n=584; 488 males, 96 females; 14 to 82 of age, 55 of median age). All the patients underwent hepatectomy. Clinical characters of patients in ruptured group and non-ruptured group were observed. All the patients received follow-up after operations, the survival and causes of death were observed. The Kaplan-Meier survival curves were drawn according to the results of follow-up, and the survival of 2 groups was compared. The relation between the clinical parameters and the prognosis of patients in ruptured group was analyzed. The clinical parameters in 2 groups were compared using Chi-square test or Fisher’s exact probability method. Multiple factors analysis between groups was conducted using Logistic regression analysis. Survival analysis and comparison were conducted using Kaplan-Meier method and Log-rank test. Prognostic risk factor analysis was conducted using Cox proportional hazards regression model analysis.

Results

The patients with non-radical resection, liver resection range > 1 segment, surgical margin < 0.5 cm, intraoperative transfusion, intraoperative blood loss ≥ 1 000 ml, tumor diameter > 5 cm and poorly differentiated tumor in ruptured group were significantly more than those in non-ruptured group (χ2=37.609, 6.021, 6.497, 20.982, 19.498, 22.944, 8.222; P<0.05). Further Logistic regression analysis showed that non-radical resection and tumor diameter > 5 cm were the independent risk factors for ruptured HCC with subclinical bleeding (OR=3.772, 5.045; P<0.05). There were 26 deaths in ruptured group and 316 deaths in non-ruptured group during the follow-up. Kaplan-Meier analysis showed that the median survival time was 9 months in ruptured group and 56 months in non-ruptured group. The 1-, 3-, 5-year accumulative survival rate were 50.0%, 22.2%, 5.9% in ruptured group and 86.0%, 62.6%, 48.9% in non-ruptured group respectively, where significant difference was observed (χ2=38.879, P<0.05). Cox proportional hazards regression model analysis showed that poorly differentiated tumor was an independent risk factor for patients in ruptured group after hepatectomy (RR=3.736, P<0.05).

Conclusions

Non-radical resection and tumor diameter > 5 cm are the independent risk factors for ruptured HCC with subclinical bleeding. The prognosis of ruptured HCC patients with subclinical bleeding after elective hepatectomy is still poor, and poorly differentiated tumor is an independent risk factor for it.

表1 破裂组与非破裂组患者临床参数的比较(例)
图1 破裂组与非破裂组患者肝切除术后Kaplan-Meier生存曲线
表2 破裂组患者肝切除术后预后的Cox比例风险回归模型分析结果
[1]
Bassi N,Caratozzolo E,Bonariol L, et al. Management of ruptured hepatocellular carcinoma: implications for therapy[J]. World J Gastroenterol, 2010, 16(10): 1221-1225.
[2]
Battula N,Madanur M,Priest O, et al. Spontaneous rupture of hepatocellular carcinoma: a Western experience[J]. Am J Surg, 2009, 197(2): 164-167.
[3]
Vergara V,Muratore A,Bouzari H, et al. Spontaneous rupture of hepatocelluar carcinoma: surgical resection and long-term survival[J]. Eur J Surg Oncol, 2000, 26(8): 770-772.
[4]
Zhu Q,Li J,Yan JJ, et al. Predictors and clinical outcomes for spontaneous rupture of hepatocellular carcinoma[J]. World J Gastroenterol, 2012, 18(48): 7302-7307.
[5]
Kogut MJ,Bastawrous S,Padia S, et al. Hepatobiliary oncologic emergencies: imaging appearances and therapeutic options[J]. Curr Probl Diagn Radiol, 2013, 42(3): 113-126.
[6]
Chong CC,Lee KF,Ip PC, et al. Pre-operative predictors of post-hepatectomy recurrence of hepatocellular carcinoma: can we predict earlier?[J]. Surgeon, 2012, 10(5): 260-266.
[7]
Chen WK,Chang YT,Chung YT, et al. Outcomes of emergency treatment in ruptured hepatocellular carcinoma in the ED[J]. Am J Emerg Med, 2005, 23(6): 730-736.
[8]
Lin CC,Chen CH,Tsang YM, et al. Diffuse intraperitoneal metastasis after spontaneous rupture of hepatocellular carcinoma[J]. J Formos Med Assoc, 2006, 105(7): 577-582.
[9]
Rossetto A,Adani GL,Risaliti A, et al. Combined approach for spontaneous rupture of hepatocellular carcinoma[J]. World J Hepatol, 2010, 2(1): 49-51.
[10]
Kim JS,Yoon SK,Kim JA, et al. Long-term survival in a patient with ruptured hepatocellular carcinoma[J]. Korean J Intern Med, 2009, 24(1): 63-67.
[11]
Cucchetti A,Qiao G,Cescon M, et al. Anatomic versus non-anatomic resection in cirrhotic patients with early hepatocellular carcinoma[J]. Surgery, 2014,155(3):512-521.
[12]
Vauthey JN,Dixon E,Abdalla EK, et al. Pretreatment assessment of hepatocellular carcinoma: expert consensus statement[J]. HPB, 2010, 12(5): 289-299.
[13]
Zhou L,Rui JA,Wang SB, et al. Prognostic factors of solitary large hepatocellular carcinoma: the importance of differentiation grade[J]. Eur J Surg Oncol, 2011, 37(6): 521-525.
[14]
Ono F,Hiraga M,Omura N, et al. Hemothorax caused by spontaneous rupture of hepatocellular carcinoma: a case report and review of the literature[J]. World J Surg Oncol, 2012(10): 215.
[15]
Llovet JM,Ricci S,Mazzaferro V, et al. Sorafenib in advanced hepatocellular carcinoma[J]. N Engl J Med, 2008, 359(4): 378-390.
[16]
Cheng AL,Kang YK,Chen Z, et al. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase Ⅲ randomised, double-blind, placebo-controlled trial[J]. Lancet Oncol, 2009, 10(1): 25-34.
[17]
吴力群,李子祥,梁军.索拉非尼联合手术或联合经导管肝动脉栓塞化疗治疗进展期肝癌的预后比较[J].肿瘤研究与临床, 2013, 25(8): 543-546.
[1] 吕琦, 惠品晶, 丁亚芳, 颜燕红. 颈动脉斑块易损性的超声造影评估及与缺血性卒中的相关性研究[J]. 中华医学超声杂志(电子版), 2023, 20(10): 1040-1045.
[2] 李越洲, 张孔玺, 李小红, 商中华. 基于生物信息学分析胃癌中PUM的预后意义[J]. 中华普通外科学文献(电子版), 2023, 17(06): 426-432.
[3] 张俊, 罗再, 段茗玉, 裘正军, 黄陈. 胃癌预后预测模型的研究进展[J]. 中华普通外科学文献(电子版), 2023, 17(06): 456-461.
[4] 马伟强, 马斌林, 吴中语, 张莹. microRNA在三阴性乳腺癌进展中发挥的作用[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 111-114.
[5] 杨倩, 李翠芳, 张婉秋. 原发性肝癌自发性破裂出血急诊TACE术后的近远期预后及影响因素分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 33-36.
[6] 王春荣, 陈姜, 喻晨. 循Glisson蒂鞘外解剖、Laennec膜入路腹腔镜解剖性左半肝切除术临床应用[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 37-40.
[7] 栗艳松, 冯会敏, 刘明超, 刘泽鹏, 姜秋霞. STIP1在三阴性乳腺癌组织中的表达及临床意义研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 52-56.
[8] 魏小勇. 原发性肝癌转化治疗焦点问题探讨[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 602-607.
[9] 潘冰, 吕少诚, 赵昕, 李立新, 郎韧, 贺强. 淋巴结清扫数目对远端胆管癌胰十二指肠切除手术疗效的影响[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 608-612.
[10] 张其坤, 商福超, 李琪, 栗光明, 王孟龙. 联合脾切除对肝癌合并门静脉高压症患者根治性切除术后的生存获益分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 613-618.
[11] 林文斌, 郑泽源, 郑文能, 郁毅刚. 外伤性脾破裂腹腔镜脾切除术患者中转开腹风险预测模型构建[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 619-623.
[12] 严庆, 刘颖, 邓斐文, 陈焕伟. 微血管侵犯对肝癌肝移植患者生存预后的影响[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 624-629.
[13] 李永胜, 孙家和, 郭书伟, 卢义康, 刘洪洲. 高龄结直肠癌患者根治术后短期并发症及其影响因素[J]. 中华临床医师杂志(电子版), 2023, 17(9): 962-967.
[14] 王军, 刘鲲鹏, 姚兰, 张华, 魏越, 索利斌, 陈骏, 苗成利, 罗成华. 腹膜后肿瘤切除术中大量输血患者的麻醉管理特点与分析[J]. 中华临床医师杂志(电子版), 2023, 17(08): 844-849.
[15] 索利斌, 刘鲲鹏, 姚兰, 张华, 魏越, 王军, 陈骏, 苗成利, 罗成华. 原发性腹膜后副神经节瘤切除术麻醉管理的特点和分析[J]. 中华临床医师杂志(电子版), 2023, 17(07): 771-776.
阅读次数
全文


摘要